Elevation of fasting morning glucose relative to hemoglobin A1c in normoglycemic patients treated with niacin and with statins

Journal of Clinical Lipidology

Volumn 6, Issue 2, 2012, Pages 168-173

  Rajanna, Veena ^a   Campbell, Kristen B ^b   Leimberger, Jeffrey ^c   Mohanty, Bibhu D ^d   Guyton, John R ^b  

^a BEAUMONT HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d MOUNT SINAI HOSPITAL   (United States)

Author keywords

Fibrates; Glucose; Hemoglobin A1c; Niacin; Statins

Indexed keywords

FASTING MORNING GLUCOSE; FIBRIC ACID DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEDTIME DOSAGE; COHORT ANALYSIS; COMBINED HYPERLIPIDEMIA; DRUG EFFECT; DRUG USE; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE;

BLOOD GLUCOSE; COHORT STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS; FASTING; FEMALE; FIBRIC ACIDS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LINEAR MODELS; MALE; MIDDLE AGED; NIACIN; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84857916523     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.12.008     Document Type: Article

References (27)

1. Coronary Drug Project Group Clofibrate and niacin in coronary heart disease J Am Med Assoc 231 1975 360 381
2. L.A. Carlson, and G. Rosenhamer Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid Acta Med Scand 223 1988 405 418
3. B.G. Brown, X.Q. Zhao, and A. Chait Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease N Engl J Med 345 2001 1583 1592 (Pubitemid 33126837)
4. E.J. Whitney, R.A. Krasuski, and B.E. Personius A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events Ann Intern Med 142 2005 95 104
5. W.E. Boden, J.L. Probstfield, T. Anderson AIM-HIGH Investigators Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
6. A. Garg, and S.M. Grundy Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus J Am Med Assoc 264 1990 723 726 (Pubitemid 20246864)
7. L.W. Gibbons, V. Gonzalez, N. Gordon, and S. Grundy The prevalence of side effects with regular and sustained-release nicotinic acid Am J Med 99 1995 378 385
8. R.B. Goldberg, and T.A. Jacobson Effects of niacin on glucose control in patients with dyslipidemia Mayo Clin Proc 83 2008 470 478 (Pubitemid 351536472)
9. P.L. Canner, C.D. Furberg, M.L. Terrin, and M.E. McGovern Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project) Am J Cardiol 95 2005 254 257 (Pubitemid 40092094)
10. S.M. Grundy, G.L. Vega, and M.E. McGovern Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes Arch Intern Med 162 2002 1568 1576
11. M.B. Elam, D.B. Hunninghake, K.B. Davis Diabetes Multicenter Research Group Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial J Am Med Assoc 284 2000 1263 1270
12. J.R. Guyton, B.G. Brown, S. Fazio, A. Polis, J.E. Tomassini, and A.M. Tershakovec Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia J Am Coll Cardiol 51 2008 1564 1572 (Pubitemid 351509420)
13. E.J. Mills, P. Wu, and G. Chong Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials Q J Med 104 2011 109 124
14. N. Sattar, D. Preiss, and H.M. Murray Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 375 2010 735 742
15. J.R. Guyton, A.C. Goldberg, and R.A. Kreisberg Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia Am J Cardiol 82 1998 737 743
16. J. Sasaki, M. Iwashita, and S. Kono Statins: beneficial or adverse for glucose metabolism J Atheroscler Thromb 13 2006 123 129
17. K.K. Koh, I. Sakuma, and M.J. Quon Differential metabolic effects of distinct statins Atherosclerosis 215 2011 1 8
18. P.M. Ridker, E. Danielson, F.A. Fonseca JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
19. P.J. Campbell, G.B. Bolli, P.E. Cryer, and J.E. Gerich Sequence of events during development of the dawn phenomenon in insulin-dependent diabetes mellitus Metabolism 34 1985 1100 1104 (Pubitemid 16186794)
20. M.I. Schmidt, Q.X. Lin, and J.T. Gwynne Fasting early morning rise in peripheral insulin: evidence of the dawn phenomenon in nondiabetes Diabetes Care 7 1984 32 35 (Pubitemid 14137230)
21. G.B. Bolli, P. De Feo, and S. De Cosmo Demonstration of a dawn phenomenon in normal human volunteers Diabetes 33 1984 1150 1153 (Pubitemid 15176846)
22. G.B. Bolli, and J.E. Gerich The "dawn phenomenon" - a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus N Engl J Med 310 1984 746 750 (Pubitemid 14161406)
23. J.R. Guyton Niacin in cardiovascular prevention: mechanisms, efficacy, and safety Curr Opin Lipidol 18 2007 415 420 (Pubitemid 47051920)
24. S. Tunaru, J. Kero, and A. Schaub PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect Nat Med 9 2003 352 355 (Pubitemid 36362793)
25. L.A. Carlson Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review J Intern Med 258 2005 94 114 (Pubitemid 41025967)
26. G.L. Vega, N.B. Cater, S. Meguro, and S.M. Grundy Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia Am J Cardiol 95 2005 1309 1313 (Pubitemid 40719861)
27. N. Thongtang, M. Ai, and S. Otokozawa Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation Am J Cardiol 107 2011 387 392